Cannell & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,852
Closed -$631K 281
2021
Q4
$631K Sell
14,852
-205,066
-93% -$8.62M 0.02% 213
2021
Q3
$9.54M Sell
219,918
-4,850
-2% -$215K 0.29% 89
2021
Q2
$9.61M Sell
224,768
-6,894
-3% -$290K 0.29% 90
2021
Q1
$8.95M Sell
231,662
-22,500
-9% -$852K 0.28% 93
2020
Q4
$9.14M Sell
254,162
-368,130
-59% -$13.3M 0.3% 85
2020
Q3
$23.8M Sell
622,292
-392,875
-39% -$15.1M 0.87% 42
2020
Q2
$35.6M Sell
1,015,167
-189,170
-16% -$6.81M 1.4% 22
2020
Q1
$39.3M Sell
1,204,337
-4,588
-0.4% -$179K 1.89% 13
2019
Q4
$55M Buy
1,208,925
+281,230
+30% +$11.8M 1.95% 13
2019
Q3
$37.7M Sell
927,695
-36,325
-4% -$1.54M 1.43% 18
2019
Q2
$41.4M Sell
964,020
-72,065
-7% -$2.77M 1.57% 19
2019
Q1
$39.8M Sell
1,036,085
-153,795
-13% -$5.87M 1.54% 16
2018
Q4
$42M Sell
1,189,880
-120,930
-9% -$4.39M 1.84% 15
2018
Q3
$50.5M Buy
1,310,810
+51,425
+4% +$1.8M 1.79% 12
2018
Q2
$41.2M Buy
1,259,385
+18,885
+2% +$570K 1.54% 20
2018
Q1
$33.9M Buy
+1,240,500
New +$33.7M 1.28% 20

Other funds holding BSX